[Utilization of high-dose norethindrone in the treatment of some genital hormono-dependent cancers].
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000368:Aged; D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy; D003537:Cystadenoma / Q000188:drug therapy; D004717:Endometrium; D004967:Estrogens / Q000652:urine; D005260:Female; D006065:Gonadotropins, Pituitary / Q000652:urine; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009640:Norethindrone / Q000008:administration & dosage* / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011276:Pregnanediol / Q000652:urine; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy*; D014626:Vaginal Smears
D015068:17-Ketosteroids; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D011276:Pregnanediol; D009640:Norethindrone
L'utilisation de la noréthindrone à doses fortes dans le traitement de certains cancers génitaux hormono-dépendants.